DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY
DEAD

Serial Number

87623179

Owner

Replimune Limited

Attorney

Melanie Howard

Filing Date

Sep 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY Trademark

Serial Number: 87623179 • Registration: 5700399

DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY is a trademark filed by Replimune Limited on September 26, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Replimune Limited (14 trademarks)

69 Innovation Dr., Milton Park, Abingdon
Oxfordshire OX144RQ , GB

Entity Type: 99

Trademark Details

Filing Date

September 26, 2017

Registration Date

March 19, 2019

Published for Opposition

January 1, 2019

Cancellation Date

October 3, 2025

Goods & Services

Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders

Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 3, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 19, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 19, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 1, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 1, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 12, 2018 NONP
1(B) BASIS DELETED; NEW BASIS REQUESTED
Nov 28, 2018 ADBS
NOTICE OF ALLOWANCE CANCELLED
Nov 28, 2018 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Nov 9, 2018 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Nov 9, 2018 PCBG
ASSIGNED TO PETITION STAFF
Nov 8, 2018 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Oct 10, 2018 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 26, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 1, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 1, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 11, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 3, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2017 NWOS
NEW APPLICATION ENTERED
Sep 29, 2017 NWAP